Back to COMMERCE BANK COMMERCE BANK

CRVSCRVS

Showing 7 of 14 quarters

Position history for COMMERCE BANKCOMMERCE BANK's holdings in CORVUS PHARMACEUTICALS INC

No. Commerce Bank exited its CRVS (Corvus Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 20,000 shares worth $154,000. Commerce Bank first reported CRVS in Q4 2022 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$105,600

Total Shares Change

-20,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$17.53
0
2025-Q4
Unchanged
20,000
0.0%
$154,0000.0%$7.49
0
2025-Q3
Unchanged
20,000
0.0%
$147,4000.0%$7.28
0
2025-Q2
Unchanged
20,000
0.0%
$80,0000.0%$3.89
0
2025-Q1
Unchanged
20,000
0.0%
$63,6000.0%$3.38
0
2024-Q4
Unchanged
20,000
0.0%
$107,0000.0%$5.25
0
2024-Q3
Unchanged
20,000
0.0%
$105,6000.0%$5.15
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used